Trial intelligence / Profile preview

Enoxaparin for Postoperative Inflammation in Pediatric Cataract Surgery

NCT00986076Phase 4Completed

Sponsor
Iladevi Cataract and IOL Research Center
Start
Mar 2008
Primary completion
Apr 2009
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of enoxaparin in post-operative inflammation, sponsored by Iladevi Cataract and IOL Research Center. Started Mar 2008; status: completed.

02

Drugs

enoxaparin
03

Conditions

post-operative inflammation

Beyond the preview

Go deeper on NCT00986076.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00986076.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call